TABLE 3.
Transplant listing data, including bridging strategy utilized before and after heart allocation change
| Before allocation change (N = 38) | After allocation change (N = 33) | P | |
|---|---|---|---|
| Days on transplant list | 314 | 49 | 0.02 |
| Called in as outpatienta (n, %) | 35 (92) | 10 (30) | <0.01 |
| Bridging strategy (n, %) | |||
| VAD | 31 (82) | 8 (24) | <0.01 |
| HM2 | 15 | 2 | |
| HM3 | 8 | 1 | |
| HVAD | 8 | 5 | |
| IABP | 1 (3) | 15 (45) | <0.01 |
| Inotropic support | 3 (8) | 5 (15) | 0.46 |
| VA-ECMO | 0 (0) | 3 (9) | 0.10 |
| Redo OHT | 2 (5) | 2 (6) | 1 |
| Noneb | 1 (3) | 0 (0) | 1 |
aPatients who were called in to the hospital while outpatient for admission to receive their heart transplant were listed as such, compared to patients that were already hospitalized for decompensated heart failure when they received their transplant.
bOne patient was admitted with multiple shocks from an implanted cardiac defibrillator and was listed as a status 1A exception for ventricular tachycardia. This patient went into PEA arrest after attempted defibrillation threshold testing and stayed in the hospital over 3 mo before transplant. The patient did not receive inotropic support or mechanical device support at any time during the hospitalization.
HM2, HeartMate 2; HM3, HeartMate 3; HVAD, HeartWare VAD; IABP, intra-aortic balloon pump; OHT, orthotopic heart transplant; VA-ECMO, venoarterial extracorporeal membrane oxygenation; VAD, ventricular assist device.